SUMMARY An excess of cancer deaths was found in grandparents of 308 children with retinoblastoma. This excess was found in all types of retinoblastoma, unilateral and bilateral, sporadic and familial. We postulated that the excess could be the result of a factor of susceptibility to cancer, different from the retinoblastoma gene, which would increase the mutation rate in retinal and germ cells as well as in other tissues.
The genetic factors in retinoblastoma have been well analysed. The two-mutational process1 allows an overall explanation of the heterogeneity of the affection. When the disease is bilateral, a germ cell mutation is the primary event and is expressed in the heterozygous state with a manifestation of almost 100 %, as the result of a second somatic mutation in several retinoblasts. A small fraction of unilateral cases have the same origin, the somatico mutations having occurred by chance in a single eye. The majority of these unilateral cases is represented by phenocopies which are the result of two successive somatic mutations.
Children have been shown to develop second primary cancers with a much higher frequency than controls.26 These tumours may be radiation-induced or non-radiogenic. Among non-radiogenic tumours, a high frequency of osteogenic sarcomas in long bones has been found. In most children who develop a second tumour, the retinoblastoma is bilateral.
Strong and Knudson4 suggested that the gene for retinoblastoma might be on the pathway to tumour formation in some tissues, in which case a second mutation would initiate a second-site tumour.
Kitchin and Ellsworth5 reached the same conclusion; they believed that the retinoblastoma locus could be related to the DNA polymerase enzyme systems.
Weichselbaum et al7 8 found increased fibroblast radiosensitivity in a patient with retinoblastoma associated with a chromosome 13 deletion. Fibroblasts in patients with familial retinoblastoma *Supported by a grant from Institut National de la Sant6 et Received for publication 4 July 1979 showed significantly higher radiosensitivities than fibroblasts derived from patients with sporadic retinoblastoma, the latter being within the normal range. The authors postulated the existence of a DNA repair defect in hereditary cases to account for the high incidence of second tumours in these patients. Some families with a particular high frequency of cancer in relatives have been published.9-11 Fedrick and Results Tables 2 and 3 give the total number of deaths and the number of deaths by cancer, respectively, for grandfathers and grandmothers, for each age-period group, separately for unilateral sporadic cases (US), bilateral sporadic cases (BS), and familial cases (Fam). Among the 621 deaths, 110 6 cancers were expected and 148 were observed. This excess is highly significant (10-4>p> 10-5). Before analysing these results more precisely, we considered whether this excess might be the result of a higher percentage of replies from families in which there were multiple cases of cancer. We compared the results obtained with the methods of data collection. In 102 cases, all the information had been obtained by direct interview. In 52 of these cases, the parents had been interviewed at the time the child was admitted to hospital (group 1). In 50 cases, they had been inter- Tables 8, 9 , and 10 show that an analysis of familial cases is difficult because the number of deaths is small when broken down into different categories. However, the following may be noted.
The excess of cancer deaths is significant when the proband is unilaterally affected but not when he is bilaterally affected.
It is also significant when the retinoblastoma gene has been transmitted through one or several unaffected relatives and not in other cases. The occurrence of second primary cancers in children with retinoblastoma has been attributed to the retinoblastoma gene. 4 5 According to this hypothesis, one would expect a higher proportion of cancer deaths among relatives who may be gene carriers than among those who probably are not.
The probability that grandparents of sporadic cases may be gene carriers can be approximately estimated from the recurrence risks in sibs. In bilateral cases, we estimated 10 to 20 % as the proportion of bilateral sporadic cases which are not the result of fresh mutations in one of the parents. 13 A new germ cell mutation may also have occurred in a grandparent, so the proportion of gene carriers among grandparents is less than 2 5 to 5 % and cannot reasonably explain the increase in susceptibility to cancer. In unilateral sporadic cases, the recurrence risk in sibs is 0 5 to 1 % which gives a proportion of carrier grandparents less than 1%, making this explanation still more unlikely.
This suggests that the factor increasing the risk of cancer in grandparents of children with retinoblastoma is different from the gene of retinoblastoma but may have some relationship with it.
According to the mutation hypothesis, this factor of susceptibility to cancer (FSC) could favour the occurrence of tumours by increasing the mutation rate in several tissues including retina and germ cells. As it is found in several members of the same family, it could be inherited, but it could also be because of common environment. The excess of cancer deaths occurring in both sides of the family in unilateral sporadic cases could mean that this factor is inherited with additive effects. However, one does not understand why this excess on both sides is not found in bilateral cases, unless this factor acts only on the first mutation. In fact, in most bilateral sporadic cases, the first mutation occurs in the germ cells of one of the parents, whereas in unilateral cases this mutation occurs in the retinal cells of the proband himself. Using such a hypothesis, one would expect, among couples of grandparents of bilateral sporadic cases where at least one was dead of cancer, an excess of couples in which both grandfather and grandmother died of cancer. In bilateral cases, there were 29 such couples and in six of them both grandparents died of cancer, whereas 3 0 were expected; this excess is not far from significance (p = 0 07, right-tailed binomial). We did not find such an excess in unilateral cases: in four of the 33 couples both grandparents died of cancer, whereas 3*0 were expected. However, the results between unilateral and bilateral cases are not different enough to permit definite conclusions.
There is another indirect argument for the FSC acting only on the first mutation. A difference of expressivity and penetrance has been noted in hereditary cases according to the manifestation in C Bonalti-Peli and ML Briard-Guillemot the carrier parent.'5 16 Offspring of bilateral cases have a higher probability of being affected and, when affected, a higher probability of bilaterality than the offspring of hereditary unilateral cases, and still higher than the offspring of unaffected carriers. According to the mutation theory, one could explain such a difference if the rate of the second (somatic) mutation were higher in bilateral cases than in unilateral cases and unaffected carriers. The correlation between expressivity and penetrance would be a consequence of the correlation between mutation rates of parent and offspring, as a result of the existence of an inherited 'mutator factor'. If this hypothetical 'mutator factor' were the same as the FSC found in grandparents, one would expect in familial cases a higher frequency of cancer among grandparents of bilateral cases and of cases from families with a high degree of penetrance than among grandparents of unilateral cases and of cases from families with several unaffected carriers, which is not found (tables 8, 9). We may conclude that the FSC has apparently no effect on the rate of the second mutation and cannot explain the differences of expressivity and penetrance among gene carriers.
Then, if the FSC acts only on the rate of the first mutation, we cannot expect an increase in cancer deaths among the familial cases who have inherited this mutation. This is, however, found, in particular when distant relatives are affected ( Thus, the best explanation of cancers occurring in patients is the pleiotropic effect of either the retinoblastoma gene, as suggested by the authors, or of a gene which would favour the manifestation of retinoblastoma in a gene carrier and produce other cancers.
We tried to explain our results, using Knudson's hypothesis of two mutational steps. Other models have been proposed: Herrmann'9 suggested that all pedigree patterns could be explained by the phenomenon of delayed mutation. Although these models do not exclude each other, there are several points of conflict; in particular, Herrmann thinks it unnecessary to postulate a sezond somatic mutation.
Matsunaga2l rejected both models and he concluded that there was little need to postulate delayed mutation, that only one mutation was involved, and that both penetrance and expressivity in a gene carrier could be defined as a variable determined by genetic and environmental factors, what he called host resistance.
Since we found that the increase in cancer deaths in grandparents of patients was not the result of the retinoblastoma gene, but of a factor which probably increases the rate of the first (or single) mutation, we cannot argue for or against any of these three hypotheses, except that the phenomenon of delayed mutation is very probable in some hereditary cases.
retinoblastoma. grandparents of patients with
Excess of cancer deaths in 
